| 靶点: |
NCX. |
| 体内研究: |
ORM-10962 (0.3 mg/kg,IV,一次) 预处理可显著延迟麻醉豚鼠心室期前收缩 (约 50%) 或室性心动过速 (约 30%) 的发生和复发。 |
| 参考文献: |
1. Kohajda Z, et al. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments. PLoS One. 2016 Nov 10;11(11):e0166041. 2. Oravecz K, et al. Inotropic effect of NCX inhibition depends on the relative activity of the reverse NCX assessed by a novel inhibitor ORM-10962 on canine ventricular myocytes. Eur J Pharmacol. 2018 Jan 5;818:278-286. 3. Kohajda Z, et al. Novel Na+/Ca2+ Exchanger Inhibitor ORM-10962 Supports Coupled Function of Funny-Current and Na+/Ca2+ Exchanger in Pacemaking of Rabbit Sinus Node Tissue. Front Pharmacol. 2020 Jan 29;10:1632. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.176 ml |
10.88 ml |
21.761 ml |
| 5 mM |
0.435 ml |
2.176 ml |
4.352 ml |
| 10 mM |
0.218 ml |
1.088 ml |
2.176 ml |
| 50 mM |
0.044 ml |
0.218 ml |
0.435 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |